Roche Holding AG
SIX:ROG
Roche Holding AG
SIX:ROG
Price:
236.9 CHF
4.13%
Updated:
May 16, 2024
Roche Holding AG
Other Equity
|
Roche Holding AG
Other Equity Peer Comparison
Comparables:
NOVN
NLSP
S
SDZ
Competitive Other Equity Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Roche Holding AG
SIX:ROG
|
Other Equity
-CHf13B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-7%
|
|
|
Novartis AG
SIX:NOVN
|
Other Equity
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
Other Equity
-$50k
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
N/A
|
|
S
|
Sandoz Group AG
SIX:SDZ
|
Other Equity
-$172m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Roche Holding AG's Other Equity?
Other Equity
-13B
CHF
-13B
CHF
Based on the financial report for Dec 31, 2023, Roche Holding AG's Other Equity amounts to -13B CHF.
What is Roche Holding AG's Other Equity growth rate?
Other Equity CAGR 10Y
-7%
-7%
Over the last year, the Other Equity growth was -19%. The average annual Other Equity growth rates for Roche Holding AG have been -11% over the past three years , -12% over the past five years , and -7% over the past ten years .
You don't have any saved screeners yet
